News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
192 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (2946)
February (2976)
March (2714)
April (2913)
May (3639)
June (2347)
Day
1 (247)
2 (153)
3 (119)
4 (61)
7 (125)
8 (120)
9 (108)
10 (98)
11 (60)
13 (8)
14 (122)
15 (104)
16 (130)
17 (119)
18 (31)
21 (89)
22 (113)
23 (192)
24 (172)
25 (121)
28 (196)
29 (201)
30 (224)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
Day
1
2
3
4
7
8
9
10
11
13
14
15
16
17
18
21
22
23
24
25
28
29
30
Venture capitalists
Bausch Health Tussles With Activist Investor Carl Icahn After Popping Poison Pill
Bausch Health has launched a shareholder rights plan—also known as a poison pill defense—designed to prevent any one entity from taking control of the company to the detriment of other shareholders.
April 23, 2025
·
1 min read
·
Tristan Manalac
Neuropsychiatric disorders
‘Strike 2?’ BMS Stumbles Again as Cobenfy Disappoints in Schizophrenia
Cobenfy’s late-stage flop is BMS’ second high-profile failure in as many weeks. The pharma announced last week that Camzyos was unable to improve disease burden in non-obstructive hypertrophic cardiomyopathy.
April 23, 2025
·
2 min read
·
Tristan Manalac
Drug pricing
Trump Wants To Bring Back International Drug Pricing Policy:
Reuters
The so-called ‘Most Favored Nations’ rule would set drug pricing for Medicare in line with the prices paid by other nations, where drugs can be much cheaper.
April 23, 2025
·
2 min read
·
Annalee Armstrong
Press Releases
Veravas Launches VeraBIND™ Tau - First Blood Test to Detect Alzheimer’s-Related Tau Pathology
April 23, 2025
·
3 min read
Press Releases
Vicore Announces Presentations at the 2025 American Thoracic Society International Conference
April 23, 2025
·
4 min read
Press Releases
Orion Group Interim Report January–March 2025
April 23, 2025
·
6 min read
Press Releases
AbTherx and Rondo Therapeutics Announce Multi-Program Antibody Discovery Collaboration
April 23, 2025
·
2 min read
Press Releases
Aptose to Present at the 2025 Bloom Burton & Co. Healthcare Investor Conference
April 23, 2025
·
3 min read
Press Releases
Cleveland Diagnostics Announces Landmark Longitudinal Study Published in Urology
April 23, 2025
·
3 min read
Press Releases
Cybin Announces Additional Strategic Clinical Site Partnerships to Support PARADIGM, a Multinational Phase 3 Program Evaluating CYB003
April 23, 2025
·
7 min read
Previous
2 of 20
Next